Skip to main content

WHAT IS CO2RE® Intima?

The CO2RE system is a simple, efficient, energy-based solution that can treat many gynecological concerns.

Contact a Provider

Learn more or schedule a visit

FAQs about CO2RE® Intima laser treatment

When should I seek medical advice?

If your skin changes in appearance (color or texture), talk to a medical professional about what can help. 

What are some genital skin concerns that can be treated with the CO₂RE system?

The CO2RE system can treat many gynecological conditions that women may experience, including:

  • Conization of the cervix such as vulvar and vaginal intraepithelial neoplasia (VIN, VAIN)
  • Condyloma acuminat
  • Leukoplakia (vulvar dystrophies)
  • Herpes vaporization
  • Urethral caruncle vaporization
  • Cervical dysplasia
  • Benign and malignant tumor
  • Erythroplasia

What can I expect following a CO₂RE treatment?

The response to treatment will vary and results appear gradually. 

What about side effects?

Speak with your physician about any side effects such as swelling, itching ,discomfort, or minor pain that could occur with energy-based treatments. For a complete list, speak to your physician.

*CO2RE System is cleared under FDA. FDA clearance number K181523.

The CO2RE system is indicated for use in surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including: aesthetic surgery (dermatology and plastic surgery), podiatry, gynecology, neurosurgery, orthopedics (soft tissue), arthroscopy (knee).

Gynecology (GYN)

Laser incision, excision, ablation and/or vaporization and of soft tissue in gynecology (GYN) for the treatment of: conization of the cervix, including cervical intraepithelial neoplasia (CIN); vulvar and vaginal intraepithelial neoplasia (VIN, VAIN); Condyloma acuminate, including cervical, genital, vulvar, perineal, and Bowenoid papulosa (BP) lesions; Leukoplakia (vulvar dystrophies); Herpes vaporization; Urethral caruncle vaporization; Cervical dysplasia; Benign and malignant tumor and hemangiomas.